The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBREI.L Regulatory News (BREI)

  • There is currently no data for BREI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

11 Nov 2021 07:00

RNS Number : 0002S
BMO Real Estate Investments Ltd
11 November 2021
 

BMO Real Estate Investments: New Research

11/11/2021

BREI's discount looks attractive and may not last given the 4.7% yield…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKFEFLSFFFA
Date   Source Headline
13th Apr 202211:36 amPRNHolding(s) in Company
1st Apr 202210:55 amPRNHolding(s) in Company
31st Mar 20227:00 amPRNInterim Results 31.12.2021
1st Mar 202210:50 amPRNInterim Dividend
24th Jan 20227:00 amPRNTrading Update and Net Asset Value
18th Nov 202110:49 amPRNResult of AGM
18th Nov 20217:00 amPRNInterim Dividend
11th Nov 20217:00 amRNSKepler Trust Intelligence: New Research
22nd Oct 20217:00 amPRNTrading Update and Net Asset Value
19th Oct 202112:21 pmPRNNotice of AGM
8th Oct 20217:00 amPRNAnnual Report
5th Oct 20217:00 amPRNProperty Transactions
9th Sep 20213:56 pmPRNResults of EGM
9th Sep 202111:07 amPRNInterim Dividend
6th Aug 202111:55 amPRNChange of Investment Policy and EGM Notice
26th Jul 20217:00 amPRNTrading Update and Net Asset Value
15th Jun 202110:38 amPRNHolding(s) in Company
11th Jun 20211:03 pmPRNDirector/PDMR Shareholding
3rd Jun 202112:48 pmPRNHolding(s) in Company
19th May 20214:36 pmPRNInterim Dividend
27th Apr 20217:00 amPRNTrading Update and Net Asset Value
8th Apr 20217:00 amPRNDirector/PDMR Shareholding
22nd Mar 20217:00 amPRNInterim Results 31.12.2020
10th Mar 20212:42 pmPRNBoard Changes
1st Mar 202112:28 pmPRNInterim Dividend
27th Jan 20217:00 amPRNTrading Update and Net Asset Value
6th Jan 20217:00 amPRNDirector/PDMR Shareholding
23rd Dec 202011:09 amPRNHolding(s) in Company
10th Dec 202012:47 pmPRNHolding(s) in Company
2nd Dec 20207:00 amPRNInterim Dividend
30th Nov 20202:29 pmPRNHolding(s) in Company
17th Nov 20202:23 pmPRNResult of AGM
22nd Oct 20207:00 amPRNTrading Update and Net Asset Value
16th Oct 202010:00 amPRNNotice of AGM
6th Oct 20207:00 amPRNDirector/PDMR Shareholding
28th Sep 20207:00 amPRNAnnual Report
4th Sep 20204:35 pmRNSPrice Monitoring Extension
26th Aug 20202:51 pmPRNInterim Dividend
16th Jul 20207:00 amPRNTrading Update and Net Asset Value
6th Jul 20208:40 amPRNDirector/PDMR Shareholding
8th Jun 202012:07 pmRNSSecond Price Monitoring Extn
8th Jun 202012:02 pmRNSPrice Monitoring Extension
3rd Jun 20207:00 amPRNInterim Dividend Announcement
7th May 202012:07 pmRNSSecond Price Monitoring Extn
7th May 202012:02 pmRNSPrice Monitoring Extension
27th Apr 20203:04 pmPRNRights attaching to shares
20th Apr 20207:00 amPRNTrading Update & Net Asset Value
16th Apr 20202:46 pmPRNHolding(s) in Company
6th Apr 20208:55 amPRNDirector/PDMR Shareholding
30th Mar 20201:50 pmPRNRefinancing Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.